DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» NMP22
NMP22
Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, P53, FGFR3 and TATI in Bladder Cancers
NMP22) As a Tumour Marker in Bladder Cancer Patients
Liquid Biopsy Biomarkers in Urine: a Route Towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer
Appendix E: Authorization Guidelines for Laboratory, Ob/Gyn, and Radiology Services (Auto Pay List)
Biomarkers for Early Detection of Cancer: a Systematic Review Towards the Identification of True Cancer Biomarkers for Early Detection
1 Tumor Markers Currently Utilized in Cancer Care Gaetano
Review of Non-Invasive Urinary Biomarkers in Bladder Cancer
Noninvasive Diagnosis of Bladder Carcinoma by Enzyme-Linked Immunosorbent Assay Detection of CD44 Isoforms in Exfoliated Urothelia
Copyrighted Material
ABSTRACTS of the 13Th INTERNATIONAL HAMBURG SYMPOSIUM on TUMOR MARKERS
Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance In
Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers Edited by Catharine M
Urine Preservative and Transport List
Unmasking Molecular Profiles of Bladder Cancer
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Sensitivity and Specificity Analysis of Urine NMP22, Cytokeratin-18, CA 19-9 and Cytology, for Diagnosing Bladder Malignancy Nur Budaya Taufiq*
Essentials of Fluid Cytology
Top View
Serum Tumor Markers for Malignancies AHS – G2124
Unmasking Molecular Profiles of Bladder Cancer
Prognostic and Predictive Markers in Early Detection of Different Types of Cancers for Selected Organ Sites
Nmp22 Is a Sensitive, Cost-Effective Test in Patients at Risk for Bladder Cancer
PDF/ Surgical Recurrence of Hepatocellular Carcinoma: Hepatocellular Carcinoma
Clinical Utility of Tumor Markers
References L-28
WO 2011/069587 Al
Urothelial Carcinoma.Pdf
Draft Report
Noninvasive Urine-Based Tests to Diagnose Or Detect Recurrence of Bladder Cancer
Tumor Markers
V3.23 Pathology and Laboratory Services Relative Value Units (Rvus)
6/27/2014 Title Tumor Markers for Diagnos
Molecular Characterization of Canine Urothelial Carcinoma: from Chromosome to Clinic
(SPBP) Covered Laboratory Services
Microrna Detection in Feces, Sputum, Pleural Effusion and Urine: Novel Tools for Cancer Screening (Review)
Detection of Bladder Cancer Via Microfluidic Immunoassay and Single-Cell DNA Copy Number Alteration Analysis of Captured Urinary Exfoliated Tumor Cells